The impact and cost-effectiveness of pneumococcal immunisation strategies for the elderly in England

The impact and cost-effectiveness of pneumococcal immunisation strategies for the elderly in England

Pneumococcal disease, presenting as invasive pneumococcal disease (IPD) or community-acquired pneumonia (CAP) is an important cause of illness and hospitalisation in the elderly. To reduce pneumococcal burden, since 2003, 65-year-olds in England have been offered a 23-valent pneumococcal polysacchar...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Danelian, G, Burton, L, Bayley, T, Sanchez-Marroquin, A, Park, J, Manley, H, Choi, Y, Andrews, N, Ladhani, S, Earnshaw, A, Gritzfeld, JF, Trotter, C, Panovska-Griffiths, J
Format:	Journal article
Sprache:	English
Veröffentlicht:	Elsevier 2024

Ähnliche Einträge

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
von: Shamez N. Ladhani, et al.
Veröffentlicht: (2013-01-01)

Combining models to generate a consensus effective reproduction number R for the COVID-19 epidemic status in England
von: Manley, H, et al.
Veröffentlicht: (2024)

Adherence to the paediatric immunisation schedule in England
von: Bauwens, J, et al.
Veröffentlicht: (2021)

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
von: Godwin Oligbu, et al.
Veröffentlicht: (2019-09-01)

Combining models to generate consensus medium-term projections of hospital admissions, occupancy and deaths relating to COVID-19 in England
von: Manley, H, et al.
Veröffentlicht: (2024)

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales
von: Abdelmajid Djennad, et al.
Veröffentlicht: (2018-12-01)

Combining models to generate consensus medium-term projections of hospital admissions, occupancy and deaths relating to COVID-19 in England
von: Harrison Manley, et al.
Veröffentlicht: (2024-05-01)

Invasive pneumococcal disease in England and Wales: vaccination implications.
von: Sleeman, K, et al.
Veröffentlicht: (2001)

Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England.
von: Foster, D, et al.
Veröffentlicht: (2011)

Inferring community transmission of SARS-CoV-2 in the United Kingdom using the ONS COVID-19 Infection Survey.
von: McCabe, R, et al.
Veröffentlicht: (2024)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
von: Ezra Linley, et al.
Veröffentlicht: (2019-01-01)

Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule
von: Bauwens, J, et al.
Veröffentlicht: (2021)

Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England
von: Marta Bertran, et al.
Veröffentlicht: (2022-08-01)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
von: Ashley Makwana, et al.
Veröffentlicht: (2018-10-01)

Inferring community transmission of SARS-CoV-2 in the United Kingdom using the ONS COVID-19 Infection Survey
von: Ruth McCabe, et al.
Veröffentlicht: (2024-06-01)

Estimating age-stratified influenza-associated invasive pneumococcal disease in England: a time-series model based on population surveillance data
von: Chiavenna, C, et al.
Veröffentlicht: (2019)

7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?
von: Yoon Hong Choi, et al.
Veröffentlicht: (2011-01-01)

Increased Invasive Pneumococcal Disease, North East England, UK
von: Catherine Houseman, et al.
Veröffentlicht: (2017-01-01)

Is immunisation child protection?
von: Finn, A, et al.
Veröffentlicht: (2011)

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
von: Foster, D, et al.
Veröffentlicht: (2008)

Genetic immunisation
von: Johnson, T, et al.
Veröffentlicht: (2021)

Presentations at the UK National Immunisation Conference
von: Pollard, AJ, et al.
Veröffentlicht: (2022)

Immunisation
von: B Farham
Veröffentlicht: (2023-04-01)

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
von: Yoon Hong Choi, et al.
Veröffentlicht: (2019-07-01)

Pneumococcal carriage and disease in adults in England, 2011–2019: the importance of adults as a reservoir for pneumococcus in communities
von: El Safadi, D, et al.
Veröffentlicht: (2024)

Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling
von: De Cao, E, et al.
Veröffentlicht: (2014)

The interplay between susceptibility and vaccine effectiveness control the timing and size of an emerging seasonal influenza wave in England
von: van Leeuwen, E, et al.
Veröffentlicht: (2023)

The interplay between susceptibility and vaccine effectiveness control the timing and size of an emerging seasonal influenza wave in England
von: E. van Leeuwen, et al.
Veröffentlicht: (2023-09-01)

Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.
von: Moore, C, et al.
Veröffentlicht: (2014)

Schedules for pneumococcal vaccination of preterm infants: an RCT
von: Kent, A, et al.
Veröffentlicht: (2016)

Immunisation status in hospitalised infants: reasons for incomplete immunisation
von: Othman, Norlijah, et al.
Veröffentlicht: (2005)

Getting it right—the Australian Childhood Immunisation Register and immunisation rates in south‐eastern Sydney
von: Susan J. Botham, et al.
Veröffentlicht: (2004-02-01)

Immunisation of adolescents in the UK.
von: Kale, A, et al.
Veröffentlicht: (2011)

Views of Zulus and Southern Sothos on immunisation
von: A.J. Lubbe
Veröffentlicht: (1984-09-01)

10-minute consultation: MMR immunisation.
von: Harnden, A, et al.
Veröffentlicht: (2001)

Paracetamol and infant immunisation
von: Ford, K, et al.
Veröffentlicht: (2007)

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply
von: Snape, MD, et al.
Veröffentlicht: (2006)

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.
von: Heath, P, et al.
Veröffentlicht: (1997)

Childhood immunisation: what is the future?
von: Pollard, A
Veröffentlicht: (2007)

Childhood immunisation: what is the future?
von: Pollard, A
Veröffentlicht: (2007)